Status
Conditions
About
COPD is a very common disease, an estimated 3 million people are affected in France. Unfortunately, this pathology is under-diagnosed. Several reasons can be mentioned: the banality of the symptoms or the several comorbidities.
Screening faces a major difficulty: the realization of a spirometry. Various studies have shown the complexity of the implementation of mass screening in cities by mini-spirometry.
The COPD World Health Days allow this mass screening but without visibility on the actual entry into a care pathway.
The objective of this study is to assess the impact of systematic screening for COPD during a tabacology consultation
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Loading...
Central trial contact
Marc Beaumont; Marianne Nicol
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal